drugset / Trial / NCT02448550
Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this trial is to determine whether bivalirudin is non-inferior to unfractionated heparin in patients with stable angina, unstable angina, or non-ST segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Timeline
- Start
- 2015-05
- Primary completion
- 2016-05-06
- Completion
- 2016-06-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bivalirudin | Peptide | — | — |
| Comparator | Heparin | Other / unclassified | — | — |
Indications
No indication recorded.